Related Experiment Video

Updated: Nov 10, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K

Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal

Theodore Gourdin1

  • 1Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, South Carolina, Charleston, USA.

Current Opinion in Oncology
|April 5, 2021
PubMed
Abstract

Insights

Recent research highlights advanced prostate cancer treatments. Novel therapies like relugolix, radioisotopes, and immunotherapy offer new options for metastatic and castration-resistant prostate cancer, improving patient outcomes.

Area of Science:

  • Oncology
  • Urology
  • Medical Research

Background:

  • Advanced prostate cancer treatment involves complex sequencing of therapies.
  • Androgen deprivation therapy (ADT) is a cornerstone, but novel agents are emerging.
  • Optimal treatment strategies for metastatic and castration-resistant disease are under continuous investigation.

Purpose of the Study:

  • To review recent research on advanced prostate cancer treatments.
  • To highlight emerging therapeutic options and their potential impact.

Main Methods:

  • Review of current scientific literature and clinical trial data.
  • Analysis of novel therapeutic agents and treatment combinations.
  • Examination of treatment sequencing in metastatic prostate cancer.

Main Results:

  • Relugolix, a novel LHRH antagonist, shows promise as an initial ADT option.
  • Novel radioisotopes, genomically selected therapies, and immunotherapy combinations are advancing treatment for castration-resistant prostate cancer.
  • Evolving data refine systemic therapy selection for treatment-naïve metastatic prostate cancer.

Conclusions:

  • New therapeutic avenues are emerging for advanced prostate cancer.
  • Innovations in ADT, radioisotopes, targeted drugs, and immunotherapy aim to improve patient outcomes.
  • Ongoing research continues to refine treatment strategies for advanced prostate cancer.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.7K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
605
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
816
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K